Skip to Content
MayoACCESS
MayoLINK
Register
My Dashboard
Test Catalog
Algorithms
Download Test Catalog & Interpretive Handbook
New Tests
NY State Informed Consent Tests
Performing Locations
Referred Tests
Specialty Testing
Test Updates
Ordering & Results
Critical Values & Results
Custom Gene Ordering
Forms
LIS Resources
MayoACCESS Resources
MayoLINK Resources
Order Your First Test
Patient Information and Signature Forms
Request Additional Testing
Send Additional Specimen
Specimen Handling
Collection & Preparation
Dangerous Goods Training
Shipping & Courier Guides
Shipping Regulations
Supplies
Customer Service
Billing
Contact Us
FAQ
IT Updates
Joint Test Catalog Admin Resources
Operational Updates
Quality & Compliance
Education & Insights
Educational Resources
News
Outreach
Podcasts
Stories
Contact
Log Out
Return to Answers From the Lab
State-of-the-art genetics panel optimizes kidney disease treatment: Linnea M. Baudhuin, Ph.D., and Emily K. Thoreson, M.S., CGC
By
Chantell Canfield
•
August 30, 2022
Share this:
Related Episodes
Breakthroughs and Trends That Defined Lab Medicine in 2025
By
Sarah Jarvis
•
December 18, 2025
Accelerating Research and Development With BioPharma Diagnostics
By
Sarah Jarvis
•
December 4, 2025
Unlocking the Unknown With Metagenomics
By
Sarah Jarvis
•
November 20, 2025
Chantell Canfield
Chantell Canfield is a web content coordinator for Mayo Clinic Laboratories. She began working for Mayo Clinic in 2021.
Related Posts
Key Updates on Today’s Regulatory Landscape for Outreach Laboratories
Dr. Bill Morice reveals how data is reshaping clinical diagnostics
5 Transformations Mayo Clinic Laboratories Advanced in 2025
